SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing agreement with Hilleman Laboratories, a vaccines and biologics.
Dr Raman Rao, CEO at Hilleman Laboratories explains how training LMICs through the Developing Countries Vaccine Manufacturers Network (DCVMN), a voluntary public health-driven alliance of vaccine manufacturers is engaged in research, development, manufacturing, and supply of high-quality vaccines and biologics